+1 347 708 0418
Non-Invasive Drug Delivery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-Invasive Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Artificial Pancreas
Needle Free Injector
Digital Respiratory Devices
Other
Segment by Application
Hospital
Clinic
Other
By Company
Adherium Limited
Capsule Technologies, Inc.
Crossject S.A.
Diabeloop SA
HNS International, Inc.
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Novartis AG
PenJet Corporation
PharmaJet
Portal Instruments
ResMed
Sensiron AG
Tandem Diabetes Care, Inc.
Teva Pharmaceuticals Industries Ltd.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Non-Invasive Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Artificial Pancreas
1.2.3 Needle Free Injector
1.2.4 Digital Respiratory Devices
1.2.5 Other
1.3 Market by Application
1.3.1 Global Non-Invasive Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-Invasive Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Non-Invasive Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-Invasive Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-Invasive Drug Delivery Sales by Region
2.4.1 Global Non-Invasive Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Non-Invasive Drug Delivery by Region (2023-2028)
2.5 Global Non-Invasive Drug Delivery Revenue by Region
2.5.1 Global Non-Invasive Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Non-Invasive Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-Invasive Drug Delivery Sales by Manufacturers
3.1.1 Global Top Non-Invasive Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Invasive Drug Delivery in 2021
3.2 Global Non-Invasive Drug Delivery Revenue by Manufacturers
3.2.1 Global Non-Invasive Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-Invasive Drug Delivery Revenue in 2021
3.3 Global Non-Invasive Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-Invasive Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-Invasive Drug Delivery Sales by Type
4.1.1 Global Non-Invasive Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Non-Invasive Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Non-Invasive Drug Delivery Revenue by Type
4.2.1 Global Non-Invasive Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Non-Invasive Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Non-Invasive Drug Delivery Price by Type
4.3.1 Global Non-Invasive Drug Delivery Price by Type (2017-2022)
4.3.2 Global Non-Invasive Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-Invasive Drug Delivery Sales by Application
5.1.1 Global Non-Invasive Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Non-Invasive Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Non-Invasive Drug Delivery Revenue by Application
5.2.1 Global Non-Invasive Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Non-Invasive Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Non-Invasive Drug Delivery Price by Application
5.3.1 Global Non-Invasive Drug Delivery Price by Application (2017-2022)
5.3.2 Global Non-Invasive Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-Invasive Drug Delivery Market Size by Type
6.1.1 North America Non-Invasive Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Non-Invasive Drug Delivery Revenue by Type (2017-2028)
6.2 North America Non-Invasive Drug Delivery Market Size by Application
6.2.1 North America Non-Invasive Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Non-Invasive Drug Delivery Revenue by Application (2017-2028)
6.3 North America Non-Invasive Drug Delivery Market Size by Country
6.3.1 North America Non-Invasive Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non-Invasive Drug Delivery Market Size by Type
7.1.1 Europe Non-Invasive Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Non-Invasive Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Non-Invasive Drug Delivery Market Size by Application
7.2.1 Europe Non-Invasive Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Non-Invasive Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Non-Invasive Drug Delivery Market Size by Country
7.3.1 Europe Non-Invasive Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Non-Invasive Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-Invasive Drug Delivery Market Size by Type
8.1.1 Asia Pacific Non-Invasive Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Non-Invasive Drug Delivery Market Size by Application
8.2.1 Asia Pacific Non-Invasive Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Non-Invasive Drug Delivery Market Size by Region
8.3.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non-Invasive Drug Delivery Market Size by Type
9.1.1 Latin America Non-Invasive Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Non-Invasive Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Non-Invasive Drug Delivery Market Size by Application
9.2.1 Latin America Non-Invasive Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Non-Invasive Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Non-Invasive Drug Delivery Market Size by Country
9.3.1 Latin America Non-Invasive Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Non-Invasive Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-Invasive Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-Invasive Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Adherium Limited
11.1.1 Adherium Limited Corporation Information
11.1.2 Adherium Limited Overview
11.1.3 Adherium Limited Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Adherium Limited Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Adherium Limited Recent Developments
11.2 Capsule Technologies, Inc.
11.2.1 Capsule Technologies, Inc. Corporation Information
11.2.2 Capsule Technologies, Inc. Overview
11.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Capsule Technologies, Inc. Recent Developments
11.3 Crossject S.A.
11.3.1 Crossject S.A. Corporation Information
11.3.2 Crossject S.A. Overview
11.3.3 Crossject S.A. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Crossject S.A. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Crossject S.A. Recent Developments
11.4 Diabeloop SA
11.4.1 Diabeloop SA Corporation Information
11.4.2 Diabeloop SA Overview
11.4.3 Diabeloop SA Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Diabeloop SA Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Diabeloop SA Recent Developments
11.5 HNS International, Inc.
11.5.1 HNS International, Inc. Corporation Information
11.5.2 HNS International, Inc. Overview
11.5.3 HNS International, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 HNS International, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HNS International, Inc. Recent Developments
11.6 Inovio Pharmaceuticals, Inc.
11.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
11.6.2 Inovio Pharmaceuticals, Inc. Overview
11.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Inovio Pharmaceuticals, Inc. Recent Developments
11.7 Medtronic Plc.
11.7.1 Medtronic Plc. Corporation Information
11.7.2 Medtronic Plc. Overview
11.7.3 Medtronic Plc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Medtronic Plc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Medtronic Plc. Recent Developments
11.8 Novartis AG
11.8.1 Novartis AG Corporation Information
11.8.2 Novartis AG Overview
11.8.3 Novartis AG Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis AG Recent Developments
11.9 PenJet Corporation
11.9.1 PenJet Corporation Corporation Information
11.9.2 PenJet Corporation Overview
11.9.3 PenJet Corporation Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PenJet Corporation Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PenJet Corporation Recent Developments
11.10 PharmaJet
11.10.1 PharmaJet Corporation Information
11.10.2 PharmaJet Overview
11.10.3 PharmaJet Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 PharmaJet Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PharmaJet Recent Developments
11.11 Portal Instruments
11.11.1 Portal Instruments Corporation Information
11.11.2 Portal Instruments Overview
11.11.3 Portal Instruments Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Portal Instruments Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Portal Instruments Recent Developments
11.12 ResMed
11.12.1 ResMed Corporation Information
11.12.2 ResMed Overview
11.12.3 ResMed Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ResMed Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ResMed Recent Developments
11.13 Sensiron AG
11.13.1 Sensiron AG Corporation Information
11.13.2 Sensiron AG Overview
11.13.3 Sensiron AG Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sensiron AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sensiron AG Recent Developments
11.14 Tandem Diabetes Care, Inc.
11.14.1 Tandem Diabetes Care, Inc. Corporation Information
11.14.2 Tandem Diabetes Care, Inc. Overview
11.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Tandem Diabetes Care, Inc. Recent Developments
11.15 Teva Pharmaceuticals Industries Ltd.
11.15.1 Teva Pharmaceuticals Industries Ltd. Corporation Information
11.15.2 Teva Pharmaceuticals Industries Ltd. Overview
11.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-Invasive Drug Delivery Industry Chain Analysis
12.2 Non-Invasive Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-Invasive Drug Delivery Production Mode & Process
12.4 Non-Invasive Drug Delivery Sales and Marketing
12.4.1 Non-Invasive Drug Delivery Sales Channels
12.4.2 Non-Invasive Drug Delivery Distributors
12.5 Non-Invasive Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-Invasive Drug Delivery Industry Trends
13.2 Non-Invasive Drug Delivery Market Drivers
13.3 Non-Invasive Drug Delivery Market Challenges
13.4 Non-Invasive Drug Delivery Market Restraints
14 Key Findings in The Global Non-Invasive Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Non-Invasive Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Artificial Pancreas
Table 3. Major Manufacturers of Needle Free Injector
Table 4. Major Manufacturers of Digital Respiratory Devices
Table 5. Major Manufacturers of Other
Table 6. Global Non-Invasive Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Non-Invasive Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 9. Global Non-Invasive Drug Delivery Sales Market Share by Region (2017-2022)
Table 10. Global Non-Invasive Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 11. Global Non-Invasive Drug Delivery Sales Market Share by Region (2023-2028)
Table 12. Global Non-Invasive Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Non-Invasive Drug Delivery Revenue Market Share by Region (2017-2022)
Table 14. Global Non-Invasive Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Non-Invasive Drug Delivery Revenue Market Share by Region (2023-2028)
Table 16. Global Non-Invasive Drug Delivery Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Non-Invasive Drug Delivery Sales Share by Manufacturers (2017-2022)
Table 18. Global Non-Invasive Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Non-Invasive Drug Delivery Revenue Share by Manufacturers (2017-2022)
Table 20. Non-Invasive Drug Delivery Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Non-Invasive Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Non-Invasive Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Drug Delivery as of 2021)
Table 23. Non-Invasive Drug Delivery Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Non-Invasive Drug Delivery Product Offered
Table 25. Date of Manufacturers Enter into Non-Invasive Drug Delivery Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 28. Global Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 29. Global Non-Invasive Drug Delivery Sales Share by Type (2017-2022)
Table 30. Global Non-Invasive Drug Delivery Sales Share by Type (2023-2028)
Table 31. Global Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Non-Invasive Drug Delivery Revenue Share by Type (2017-2022)
Table 34. Global Non-Invasive Drug Delivery Revenue Share by Type (2023-2028)
Table 35. Non-Invasive Drug Delivery Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Non-Invasive Drug Delivery Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 38. Global Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 39. Global Non-Invasive Drug Delivery Sales Share by Application (2017-2022)
Table 40. Global Non-Invasive Drug Delivery Sales Share by Application (2023-2028)
Table 41. Global Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Non-Invasive Drug Delivery Revenue Share by Application (2017-2022)
Table 44. Global Non-Invasive Drug Delivery Revenue Share by Application (2023-2028)
Table 45. Non-Invasive Drug Delivery Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Non-Invasive Drug Delivery Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 48. North America Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 49. North America Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 52. North America Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 53. North America Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 56. North America Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 57. North America Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 60. Europe Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 61. Europe Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 64. Europe Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 65. Europe Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 68. Europe Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 69. Europe Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Non-Invasive Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Non-Invasive Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Non-Invasive Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Non-Invasive Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Non-Invasive Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Non-Invasive Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Non-Invasive Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Non-Invasive Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Non-Invasive Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Non-Invasive Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Non-Invasive Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Non-Invasive Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Non-Invasive Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 107. Adherium Limited Corporation Information
Table 108. Adherium Limited Description and Major Businesses
Table 109. Adherium Limited Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Adherium Limited Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Adherium Limited Recent Developments
Table 112. Capsule Technologies, Inc. Corporation Information
Table 113. Capsule Technologies, Inc. Description and Major Businesses
Table 114. Capsule Technologies, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Capsule Technologies, Inc. Recent Developments
Table 117. Crossject S.A. Corporation Information
Table 118. Crossject S.A. Description and Major Businesses
Table 119. Crossject S.A. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Crossject S.A. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Crossject S.A. Recent Developments
Table 122. Diabeloop SA Corporation Information
Table 123. Diabeloop SA Description and Major Businesses
Table 124. Diabeloop SA Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Diabeloop SA Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Diabeloop SA Recent Developments
Table 127. HNS International, Inc. Corporation Information
Table 128. HNS International, Inc. Description and Major Businesses
Table 129. HNS International, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. HNS International, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. HNS International, Inc. Recent Developments
Table 132. Inovio Pharmaceuticals, Inc. Corporation Information
Table 133. Inovio Pharmaceuticals, Inc. Description and Major Businesses
Table 134. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Inovio Pharmaceuticals, Inc. Recent Developments
Table 137. Medtronic Plc. Corporation Information
Table 138. Medtronic Plc. Description and Major Businesses
Table 139. Medtronic Plc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Medtronic Plc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Medtronic Plc. Recent Developments
Table 142. Novartis AG Corporation Information
Table 143. Novartis AG Description and Major Businesses
Table 144. Novartis AG Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Novartis AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Novartis AG Recent Developments
Table 147. PenJet Corporation Corporation Information
Table 148. PenJet Corporation Description and Major Businesses
Table 149. PenJet Corporation Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. PenJet Corporation Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. PenJet Corporation Recent Developments
Table 152. PharmaJet Corporation Information
Table 153. PharmaJet Description and Major Businesses
Table 154. PharmaJet Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. PharmaJet Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. PharmaJet Recent Developments
Table 157. Portal Instruments Corporation Information
Table 158. Portal Instruments Description and Major Businesses
Table 159. Portal Instruments Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Portal Instruments Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Portal Instruments Recent Developments
Table 162. ResMed Corporation Information
Table 163. ResMed Description and Major Businesses
Table 164. ResMed Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. ResMed Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. ResMed Recent Developments
Table 167. Sensiron AG Corporation Information
Table 168. Sensiron AG Description and Major Businesses
Table 169. Sensiron AG Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Sensiron AG Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Sensiron AG Recent Developments
Table 172. Tandem Diabetes Care, Inc. Corporation Information
Table 173. Tandem Diabetes Care, Inc. Description and Major Businesses
Table 174. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Tandem Diabetes Care, Inc. Recent Developments
Table 177. Teva Pharmaceuticals Industries Ltd. Corporation Information
Table 178. Teva Pharmaceuticals Industries Ltd. Description and Major Businesses
Table 179. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Teva Pharmaceuticals Industries Ltd. Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Non-Invasive Drug Delivery Distributors List
Table 185. Non-Invasive Drug Delivery Customers List
Table 186. Non-Invasive Drug Delivery Market Trends
Table 187. Non-Invasive Drug Delivery Market Drivers
Table 188. Non-Invasive Drug Delivery Market Challenges
Table 189. Non-Invasive Drug Delivery Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Invasive Drug Delivery Product Picture
Figure 3. Global Non-Invasive Drug Delivery Market Share by Type in 2021 & 2028
Figure 3. Artificial Pancreas Product Picture
Figure 4. Needle Free Injector Product Picture
Figure 5. Digital Respiratory Devices Product Picture
Figure 6. Other Product Picture
Figure 7. Global Non-Invasive Drug Delivery Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Non-Invasive Drug Delivery Report Years Considered
Figure 12. Global Non-Invasive Drug Delivery Sales 2017-2028 (K Units)
Figure 13. Global Non-Invasive Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Non-Invasive Drug Delivery Revenue 2017-2028 (US$ Million)
Figure 15. Global Non-Invasive Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Non-Invasive Drug Delivery Sales Market Share by Region (2017-2022)
Figure 17. Global Non-Invasive Drug Delivery Sales Market Share by Region (2023-2028)
Figure 18. North America Non-Invasive Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 19. North America Non-Invasive Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Non-Invasive Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Non-Invasive Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Non-Invasive Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Non-Invasive Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Non-Invasive Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Non-Invasive Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Non-Invasive Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Non-Invasive Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Non-Invasive Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Non-Invasive Drug Delivery in the World: Market Share by Non-Invasive Drug Delivery Revenue in 2021
Figure 30. Global Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 32. Global Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 33. Global Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 34. Global Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 35. North America Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 36. North America Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 37. North America Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 38. North America Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 39. North America Non-Invasive Drug Delivery Sales Share by Country (2017-2028)
Figure 40. North America Non-Invasive Drug Delivery Revenue Share by Country (2017-2028)
Figure 41. U.S. Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 44. Europe Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 45. Europe Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 46. Europe Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 47. Europe Non-Invasive Drug Delivery Sales Share by Country (2017-2028)
Figure 48. Europe Non-Invasive Drug Delivery Revenue Share by Country (2017-2028)
Figure 49. Germany Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 50. France Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Non-Invasive Drug Delivery Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Non-Invasive Drug Delivery Revenue Share by Region (2017-2028)
Figure 60. China Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 63. India Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 71. Latin America Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 73. Latin America Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Non-Invasive Drug Delivery Sales Share by Country (2017-2028)
Figure 75. Latin America Non-Invasive Drug Delivery Revenue Share by Country (2017-2028)
Figure 76. Mexico Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Non-Invasive Drug Delivery Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Non-Invasive Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Non-Invasive Drug Delivery Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Non-Invasive Drug Delivery Revenue Share by Country (2017-2028)
Figure 85. Turkey Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Non-Invasive Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 88. Non-Invasive Drug Delivery Value Chain
Figure 89. Non-Invasive Drug Delivery Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Buy
